tm
Seeing Is Believing
tm
Seeing Is Believing
Currently out of the existing stock ratings of Tejas Savant, 66 are a HOLD (39.05%), 9 are a SELL (5.33%), 94 are a BUY (55.62%).
Analyst Tejas Savant, currently employed at MORGAN STANLEY, carries an average stock price target met ratio of 36.74% that have a potential upside of 17.48% achieved within 61 days.
Tejas Savant’s has documented 377 price targets and ratings displayed on 31 stocks. The coverage is on Healthcare, Basic Materials sectors.
Most recent stock forecast was given on AKYA, Akoya Biosciences at 03-Jun-2024.
Analyst best performing recommendations are on NVTA (INVITAE CORP).
The best stock recommendation documented was for NSTG (NANOSTRING TECHNOLOGIES) at 11/10/2020. The price target of $44 was fulfilled within 1 day with a profit of $4.58 (11.62%) receiving and performance score of 116.18.
Average potential price target upside
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
5
$0.96 (23.76%)
30
3 months 22 days ago
2/6 (33.33%)
$2.27 (83.15%)
58
Hold
5
$0.96 (23.76%)
63
5 months 10 days ago
1/3 (33.33%)
$1.15 (29.87%)
201
Buy
6
$1.96 (48.51%)
13
8 months 13 days ago
5/10 (50%)
$2.54 (73.41%)
56
Hold
10
$5.96 (147.52%)
13
9 months 2 days ago
1/6 (16.67%)
$5.31 (113.22%)
5
Sell
7
$2.96 (73.27%)
8
1 years 5 months 11 days ago
2/2 (100%)
$-3.03 (-30.21%)
50
Which stock is Tejas Savant is most bullish on?
Which stock is Tejas Savant is most reserved on?
What Year was the first public recommendation made by Tejas Savant?
